Denis FORTIER

This profile gathers the share dealings of Denis FORTIER in Eurobio-Scientific, where the filings describe the role as chief executive. In total, 19 filings cover trades dated from 4 May 2021 to 5 December 2024.

The open-market side counts 3 purchases for €49k alongside 9 sales for €4.4M. Taken together, the sales exceed the purchases by €4.4M. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay.

In size, the median ticket on the buying side is €17k. The 3 purchases reviewed show no overlap with other insiders buying the same stock within a month. Looking at 3 purchases old enough to measure, the stock rose over the following 90 days in 33% of cases; the median change was -2.8%. Past outcomes like these are no guarantee of what comes next.

The newest entry dates from 6 December 2024: a transaction of €146k, in Eurobio-Scientific. The latest purchase dates back some time: it was published 1,031 days ago, on 21 December 2023. Typically, a trade is published a median of 8 days after it takes place. The legal deadline for notifying a trade is three business days (MAR article 19). A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. Source: insider filings from AMF. Past trades are no guide to future returns.